Ítem
Acceso Abierto

Análisis de la pertinencia de escalas de evaluación cognitiva y de funcionamiento ocupacional para el tamizaje y diagnóstico de alteraciones neurocognitivas asociadas al VIH. revisión sistemática de la literatura

Mostrar el registro sencillo de la publicación
dc.contributor.advisorMolina Castaño, Carlos Federico
dc.creatorEstrada Bonilla, Maryi Viviana
dc.creatorAguia Rojas, Karen
dc.creator.degreeMagíster en epidemiologíaspa
dc.creator.degreetypeFull timespa
dc.date.accessioned2019-10-29T12:06:17Z
dc.date.available2019-10-29T12:06:17Z
dc.date.created2019-10-21
dc.descriptionEl Desorden Neurocognitivo Asociado a VIH (HAND) se reconoce como una problemática actual en población que vive con VIH. Los procesos de evaluación para el tamizaje y diagnóstico del HAND son heterogéneos y escasos de consenso. Esto ha generado diferencias en el reporte de prevalencias a nivel mundial y dificultades en la identificación de datos comparativos. Se realizó una revisión sistemática de literatura para determinar la pertinencia de escalas de evaluación cognitiva y de funcionamiento ocupacional para el tamizaje y diagnóstico de HAND analizando dominios cognitivos, tamizaje, participación ocupacional y salud mental. Se incluyeron 114 estudios de corte transversal, casos y controles, cohorte y ensayos clínicos. Se identificaron las escalas Trail Making Test (TMT) y Stroop Color Word Test (SCWT) como las de mayor pertinencia para la evaluación de dominios cognitivos. A nivel de participación ocupacional se requiere mayor uso de instrumentos dirigidos a evaluar el desempeño ocupacional durante la ejecución de actividades, que complementen las escalas de autorreporte como el Índice de Lawton y Brody y el Inventario para la Valoración del Propio Funcionamiento del Paciente (PAOFI). En salud mental se determina como una variable a evaluar de manera transversal por considerarse un factor de confusión en el diagnóstico de HAND.spa
dc.description.abstractHIV-Associated Neurocognitive Disorder (HAND) is recognized as a current issue in people living with HIV (PLWH). Assessment processes for screening and diagnosis of HAND are heterogeneous y lack of consensus. This has triggered differences in prevalence report across the word and difficulties in the identification of comparable data. A systematic review was conducted to determine pertinence of cognitive assessment and occupational functioning scales for HAND screening and diagnosis analyzing cognitive domains, screening, occupational participation and mental health. There were 114 cross-sectional, case and control, cohort, and clinical trials studies included in the systematic review. Trail Making Test (TMT) and Stroop Color Word Test (SCWT) scales were identified as the most pertinent para cognitive domains assessment. As for occupational participation, instruments focusing on evaluation occupational performance during the execution of activities are needed, for complementing self-report scales such as The Patients Assessment of Own Functioning Inventory (PAOFI). Mental health is determined as a variable to evaluate transversally, due to the fact that is considered a confounding in the diagnosis of HAND.spa
dc.description.embargo2021-10-30 01:01:01: Script de automatizacion de embargos. info:eu-repo/date/embargoEnd/2021-10-29
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.48713/10336_20501
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/20501
dc.language.isospaspa
dc.publisherUniversidad del Rosariospa
dc.publisher.departmentMaestría en Actividad Física y Saludspa
dc.publisher.otherUniversidad CESspa
dc.publisher.programMaestría en Epidemiologíaspa
dc.rightsAtribución-SinDerivadas 2.5 Colombiaspa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.spa
dc.rights.urihttp://creativecommons.org/licenses/by-nd/2.5/co/
dc.source.bibliographicCitationCenters for Disease Control and Prevention (CDC). HIV/AIDS [Internet]. 2019 [citado 21 de julio de 2019]. Disponible en: https://www.cdc.gov/hiv/basics/whatishiv.htmlspa
dc.source.bibliographicCitationUNAIDS. AIDSinfo [Internet]. [citado 21 de julio de 2019]. Disponible en: https://aidsinfo.unaids.org/spa
dc.source.bibliographicCitationRobertson K, Liner J, Heaton R. Neuropsychological Assessment of HIV-Infected Populations in International Settings. Neuropsychol Rev. 1 de junio de 2009;19(2):232-49.spa
dc.source.bibliographicCitationOpacich K. Human Immunodefciency Virus. En: Trombly Latham C, Vining Radomski M, editores. Occupational therapy for physical dysfunction. Seventh edition. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2014. p. 1353-7.spa
dc.source.bibliographicCitationGustafson DR, Mielke MM, Tien PC, Valcour V, Cohen M, Anastos K, et al. Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women’s Interagency HIV Study. J Neurovirol. diciembre de 2013;19(6):574-85.spa
dc.source.bibliographicCitationLawler K, Jeremiah K, Mosepele M, Ratcliffe SJ, Cherry C, Seloilwe E, et al. Neurobehavioral Effects in HIV-Positive Individuals Receiving Highly Active Antiretroviral Therapy (HAART) in Gaborone, Botswana. Myer L, editor. PLoS ONE. 18 de febrero de 2011;6(2):e17233.spa
dc.source.bibliographicCitationBonnet F, Amieva H, Marquant F, Bernard C, Bruyand M, Dauchy F-A, et al. Cognitive disorders in HIV-infected patients: are they HIV-related? AIDS. enero de 2013;27(3):391-400.spa
dc.source.bibliographicCitationTierney SM, Sheppard DP, Kordovski VM, Faytell MP, Avci G, Woods SP. A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders. J Neurovirol. junio de 2017;23(3):404-21.spa
dc.source.bibliographicCitationPalacio M, Álvarez S, Muñoz-Fernández MÁ. HIV-1 infection and neurocognitive impairment in the current era: NeuroAIDS in the current era. Rev Med Virol. enero de 2012;22(1):33-45.spa
dc.source.bibliographicCitationGrant I, Franklin DR, Deutsch R, Woods SP, Vaida F, Ellis RJ, et al. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 10 de junio de 2014;82(23):2055-62.spa
dc.source.bibliographicCitationLivelli A, Orofino GC, Calcagno A, Farenga M, Penoncelli D, Guastavigna M, et al. Evaluation of a Cognitive Rehabilitation Protocol in HIV Patients with Associated Neurocognitive Disorders: Efficacy and Stability Over Time. Front Behav Neurosci [Internet]. 16 de noviembre de 2015 [citado 21 de julio de 2019];9. Disponible en: http://journal.frontiersin.org/Article/10.3389/fnbeh.2015.00306/abstractspa
dc.source.bibliographicCitationGuía Clínica EACS 2017 [Internet]. 2017 oct p. 73. Disponible en: http://www.eacsociety.org/files/guidlines-9.0-spanish.pdfspa
dc.source.bibliographicCitationRobbins RN, Joska JA, Thomas KGF, Stein DJ, Linda T, Mellins CA, et al. Exploring the Utility of the Montreal Cognitive Assessment to Detect HIV-Associated Neurocognitive Disorder: The Challenge and Need for Culturally Valid Screening Tests in South Africa. Clin Neuropsychol. abril de 2013;27(3):437-54.spa
dc.source.bibliographicCitationHill-Jarrett TG, Ikanga J, Stringer AY. Neuropsychology in Africa. Neuropsychol Afr Encycl Clin Neuropsychol. 2018;2444.spa
dc.source.bibliographicCitationLopardo GD, Bissio E, Iannella M del C, Crespo AD, Garone DB, Cassetti LI. Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection. J Acquir Immune Defic Syndr 1999. 1 de diciembre de 2009;52(4):488-92.spa
dc.source.bibliographicCitationHinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS Lond Engl. 1 de enero de 2004;18 Suppl 1:S19-25.spa
dc.source.bibliographicCitationThe Mind Exchange Working Group, Antinori A, Arendt G, Grant I, Letendre S, Chair, et al. Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program. Clin Infect Dis. 1 de abril de 2013;56(7):1004-17.spa
dc.source.bibliographicCitationCarvalhal A, Gill MJ, Letendre SL, Rachlis A, Bekele T, Raboud J, et al. Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study. J Neurovirol. junio de 2016;22(3):349-57spa
dc.source.bibliographicCitationKamminga J, Cysique LA, Lu G, Batchelor J, Brew BJ. Validity of cognitive screens for HIV-associated neurocognitive disorder: a systematic review and an informed screen selection guide. Curr HIV/AIDS Rep. diciembre de 2013;10(4):342-55.spa
dc.source.bibliographicCitationAnderson AM, Lennox JL, Nguyen ML, Waldrop-Valverde D, Tyor WR, Loring DW. Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment. J Neurovirol. 2016;22(6):816-22.spa
dc.source.bibliographicCitationThe Mind Exchange Working Group, Antinori A, Arendt G, Grant I, Letendre S, Chair, et al. Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program. Clin Infect Dis. 1 de abril de 2013;56(7):1004-17.spa
dc.source.bibliographicCitationJoint United Nations Programme on HIV/AIDS (UNAIDS). Global Report: UNAIDS report on the global AIDS epidemic 2013. 2013. 31. Joint United Nations Programme on HIV/AIDS (UN)spa
dc.source.bibliographicCitationBennett JE, Dolin R, Blaser MJ, editores. Neurological Diseases Caused by Human Immunodeficiency Virus. En: Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Eighth edition. Philadelphia, PA: Elsevier/Saunders; 2015. p. 1482-588.spa
dc.source.bibliographicCitationSu T, Schouten J, Geurtsen GJ, Wit FW, Stolte IG, Prins M, et al. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection: AIDS. enero de 2015;1.spa
dc.source.bibliographicCitationKallail KJ, Downs D, Scherz J, Sweet D, Zackula RE. Prevalence of Communication Disorders in HIV-Infected Adults. J Int Assoc Provid AIDS Care JIAPAC. enero de 2014;13(1):8-11.spa
dc.source.bibliographicCitationMaj M, Satz P, Janssen R, Zaudig M, Starace F, D’Elia L, et al. WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry. enero de 1994;51(1):51-61.spa
dc.source.bibliographicCitationthe AIDS Clinical Trials Group, Robertson K, Kumwenda J, Supparatpinyo K, Jiang JH, Evans S, et al. A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings. J Neurovirol. octubre de 2011;17(5):438-47.spa
dc.source.bibliographicCitationSacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, et al. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology. 26 de enero de 2016;86(4):334-40.spa
dc.source.bibliographicCitationTroncoso FT, Conterno L de O. Prevalence of neurocognitive disorders and depression in a Brazilian HIV population. Rev Soc Bras Med Trop. agosto de 2015;48(4):390-8.spa
dc.source.bibliographicCitationWojna V, Skolasky RL, Hechavarría R, Mayo R, Selnes O, McArthur JC, et al. Prevalence of human immunodeficiency virus–associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol. enero de 2006;12(5):356-64.spa
dc.source.bibliographicCitationMorales D, Acevedo SF, Skolasky RL, Hechavarria R, Santiago S, De La Torre T, et al. Translational spatial task and its relationship to HIV-associated neurocognitive disorders and apolipoprotein E in HIV-seropositive women. J Neurovirol. diciembre de 2012;18(6):488-502.spa
dc.source.bibliographicCitationLadrón de Guevara H. A, Salas R. M, González B. E, Araya Cortéz L. Diagnóstico neurológico y psicológico en la evaluación del paciente VIH. Bol Hosp S Juan Dios. agosto de 1998;45(4):222-8.spa
dc.source.bibliographicCitationFondo Colombiano de Enfermedades de Alto Costo (CAC). Situación del VIH Sida en Colombia [Internet]. Bogotá, Colombia; Report No.: ISSN: 2344-7702. Disponible en: http://cuentadealtocosto.org/images/Publicaciones/2018/Situacion_VIH_2017..pdfspa
dc.source.bibliographicCitationMinisterio de Salud de Colombia. Boletín de Salud Mental - Demencia [Internet]. Subdirección de enfermedades no transmisibles; Report No.: Boletín de Salud Mental No. 3, octubre de 2017. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/Boletin-demencia-salud-mental.pdfspa
dc.source.bibliographicCitationMinisterio de Salud y Protección Social, Fondo de Población de las Naciones Unidas - UNFPA. Guía de Práctica Clínica (GPC) basada en la evidencia científica para la atención de la infección por VIH/Sida en adolescentes (con 13 años o más de edad) y adultos. [Internet]. Bogotá, Colombia; 2014. Disponible en: http://gpc.minsalud.gov.co/gpc_sites/Repositorio/Otros_conv/GPC_VIH_adolescentes/GPC_vih_adolescentes_profesionales.aspxspa
dc.source.bibliographicCitationPino-Melgarejo M, Omar-Martínez E. Cognición y VIH. Algunas consideraciones. Santiago. septiembre de 2014;(135):664-74.spa
dc.source.bibliographicCitationBennett JE, Dolin R, Blaser MJ, editores. General manifestations of Human Immunodeficiency virus infection. En: Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Eighth edition. Philadelphia, PA: Elsevier/Saunders; 2015. p. 1547.spa
dc.source.bibliographicCitationMcArthur JC, Steiner J, Sacktor N, Nath A. HIV-associated neurocognitive disorders: ‘mind the gap’. Ann Neurol. 2010;NA-NA.spa
dc.source.bibliographicCitationVan Gorp W, Root J. CNS infection: HIV associated neurocognitive compromise. En: Textbook of Clinical Neuropsychology. Great Britain: Taylor & Francis; p. 508-20.spa
dc.source.bibliographicCitationGrant I, Sacktor N. HIV-Associated Neurocognitive Disorders. En: Gendelman HE, editor. The neurology of AIDS. New York: Oxford University Press; 2012. p. 408.spa
dc.source.bibliographicCitationTozzi V, Balestra P, Galgani S, Narciso P, Ferri F, Sebastiani G, et al. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. Aids. 1999;13(14):1889–1897.spa
dc.source.bibliographicCitationAntinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–1799.spa
dc.source.bibliographicCitationValcour V, Paul R, Chiao S, Wendelken LA, Miller B. Screening for Cognitive Impairment in Human Immunodeficiency Virus. Clin Infect Dis. 15 de octubre de 2011;53(8):836-42.spa
dc.source.bibliographicCitationGandhi NS, Moxley RT, Creighton J, Roosa HV, Skolasky RL, Selnes OA, et al. Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder. HIV Ther. mayo de 2010;4(3):371-9.spa
dc.source.bibliographicCitationMcArthur JC, Steiner J, Sacktor N, Nath A. HIV-associated neurocognitive disorders: ‘mind the gap’. Ann Neurol. 2010;NA-NA.spa
dc.source.bibliographicCitationGandhi NS, Moxley RT, Creighton J, Roosa HV, Skolasky RL, Selnes OA, et al. Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder. HIV Ther. mayo de 2010;4(3):371-9.spa
dc.source.bibliographicCitationGisslén M, Price RW, Nilsson S. The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis [Internet]. diciembre de 2011 [citado 21 de julio de 2019];11(1). Disponible en: https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-11-356spa
dc.source.bibliographicCitationMcArthur JC, Steiner J, Sacktor N, Nath A. Human immunodeficiency virus-associated neurocognitive disorders mind the gap. Ann Neurol. 2010;67(6):699-714.spa
dc.source.bibliographicCitationNeuropsychological Assessment of HIV-Infected Populations in International Settings | SpringerLink [Internet]. [citado 13 de julio de 2019]. Disponible en: https://link-springer-com.ez.urosario.edu.co/article/10.1007%2Fs11065-009-9096-zspa
dc.source.bibliographicCitationThe Translational Methamphetamine AIDS Research Center (TMARC) Group, Doyle KL, Morgan EE, Morris S, Smith DM, Little S, et al. Real-world impact of neurocognitive deficits in acute and early HIV infection. J Neurovirol. diciembre de 2013;19(6):565-73.spa
dc.source.bibliographicCitationHeaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc [Internet]. mayo de 2004 [citado 21 de julio de 2019];10(03). Disponible en: http://www.journals.cambridge.org/abstract_S1355617704102130spa
dc.source.bibliographicCitationThomas H. Step 1: Determine what is being analyzed. En: Occupation-based activity analysis. Second edition. Thorofare, NJ: SLACK Incorporated; 2015. p. 19.spa
dc.source.bibliographicCitationGillen G, Boyt Schell BA. Introducción a la evaluación, la intervención y los resultados de las ocupaciones. En: Terapia ocupacional. 12a ed. Buenos Aires: Editorial Médica Panamericana; 2016. p. 607.spa
dc.source.bibliographicCitationValcour V, Paul R, Chiao S, Wendelken LA, Miller B. Screening for Cognitive Impairment in Human Immunodeficiency Virus. Clin Infect Dis. 15 de octubre de 2011;53(8):836-42.spa
dc.source.bibliographicCitationEmlet CA. A Comparison of HIV Stigma and Disclosure Patterns Between Older and Younger Adults Living with HIV/AIDS. AIDS Patient Care STDs. mayo de 2006;20(5):350-8.spa
dc.source.bibliographicCitationEmlet CA, Farkas KJ. A Descriptive Analysis of Older Adults with HIV/AIDS in California. Health Soc Work. noviembre de 2001;26(4):226.spa
dc.source.bibliographicCitationShippy RA, Karpiak SE. The aging HIV/AIDS population: Fragile social networks. Aging Ment Health. mayo de 2005;9(3):246-54.spa
dc.source.bibliographicCitationWoods SP, Moore DJ, Weber E, Grant I. Cognitive Neuropsychology of HIV-Associated Neurocognitive Disorders. Neuropsychol Rev. junio de 2009;19(2):152-68.spa
dc.source.bibliographicCitationRanka JL, Chapparo CJ. Assessment of productivity performance in men with HIV Associated Neurocognitive Disorder (HAND). Work. 2010;(2):193–206.spa
dc.source.bibliographicCitationRanka J. Cognitive Strategy Application during Everyday Task Performance in Men with HIV-1 Dementia. :282.spa
dc.source.bibliographicCitationSacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, et al. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology. 26 de enero de 2016;86(4):334-40spa
dc.source.bibliographicCitationGallego L, Barreiro P, López-Ibor JJ. Diagnosis and clinical features of major neuropsychiatric disorders in HIV infection. AIDS Rev. septiembre de 2011;13(3):171-9.spa
dc.source.bibliographicCitationHaddow LJ, Floyd S, Copas A, Gilson RJC. A Systematic Review of the Screening Accuracy of the HIV Dementia Scale and International HIV Dementia Scale. Jiang S, editor. PLoS ONE. 16 de abril de 2013;8(4):e61826.spa
dc.source.bibliographicCitationAntinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–1799.spa
dc.source.bibliographicCitationDevelopment of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS) | BMJ Open [Internet]. [citado 22 de julio de 2019]. Disponible en: https://bmjopen.bmj.com/content/6/12/e011458spa
dc.source.bibliographicCitationWells G, Shea B, O’Connell D, Peterson J, Welch M, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Internet]. [citado 22 de julio de 2019]. Disponible en: http://www.ohri.ca/programs/clinical_epidemiology/oxford.aspspa
dc.source.bibliographicCitationHartmann KE, Jerome RN, Lindegren ML, Potter SA, Shields TC, Surawicz TS, et al. Cochrane Risk of Bias Tool [Internet]. Agency for Healthcare Research and Quality (US); 2013 [citado 28 de julio de 2019]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK132494/spa
dc.source.bibliographicCitationSu T, Schouten J, Geurtsen GJ, Wit FW, Stolte IG, Prins M, et al. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection: AIDS. enero de 2015;1.spa
dc.source.bibliographicCitationTierney SM, Sheppard DP, Kordovski VM, Faytell MP, Avci G, Woods SP. A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders. J Neurovirol. junio de 2017;23(3):404-21.spa
dc.source.bibliographicCitationKinuthia RN, Gakinya BN, Thigiti JM. Relationship between HIV stage and psychomotor speed neurocognitive score at a Kenyan sub-county hospital. Afr J Prim Health Care Fam Med. 31 de agosto de 2016;8(1):e1-8.spa
dc.source.bibliographicCitationZhang Y, Qiao L, Ding W, Wei F, Zhao Q, Wang X, et al. An initial screening for HIV-associated neurocognitive disorders of HIV-1 infected patients in China. J Neurovirol. abril de 2012;18(2):120-6.spa
dc.source.bibliographicCitationHeaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. febrero de 2011;17(1):3-16.spa
dc.source.bibliographicCitationSalawu FK, Bwala SA, Wakil MA, Bani B, Bukbuk DN, Kida I. Cognitive function in HIV-seropositive Nigerians without AIDS. J Neurol Sci. 15 de abril de 2008;267(1):142-6.spa
dc.source.bibliographicCitationBlackstone K, Moore DJ, Heaton RK, Franklin DR, Woods SP, Clifford DB, et al. Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc JINS. enero de 2012;18(1):79-88.spa
dc.source.bibliographicCitationSacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. abril de 2002;8(2):136-42.spa
dc.source.bibliographicCitationYakasai AM, Gudaji MI, Muhammad H, Ibrahim A, Owolabi LF, Ibrahim DA, et al. Prevalence and Correlates of HIV-Associated Neurocognitive Disorders (HAND) in Northwestern Nigeria. Neurol Res Int. 2015;2015:486960.spa
dc.source.bibliographicCitationMarquine MJ, Sakamoto M, Dufour C, Rooney A, Fazeli P, Umlauf A, et al. The impact of ethnicity/race on the association between the Veterans Aging Cohort Study (VACS) Index and neurocognitive function among HIV-infected persons. J Neurovirol. 2016;22(4):442-54.spa
dc.source.bibliographicCitationFaílde-Garrido JM, Alvarez MR, Simón-López MA. Neuropsychological impairment and gender differences in HIV-1 infection. Psychiatry Clin Neurosci. octubre de 2008;62(5):494-502.spa
dc.source.bibliographicCitationDufour CA, Marquine MJ, Fazeli PL, Henry BL, Ellis RJ, Grant I, et al. Physical exercise is associated with less neurocognitive impairment among HIV-infected adults. J Neurovirol. octubre de 2013;19(5):410-7.spa
dc.source.bibliographicCitationSalthouse TA. What cognitive abilities are involved in trail-making performance? Intelligence. julio de 2011;39(4):222-32.spa
dc.source.bibliographicCitationScarpina F, Tagini S. The Stroop Color and Word Test. Front Psychol [Internet]. 12 de abril de 2017 [citado 14 de octubre de 2019];8. Disponible en: http://journal.frontiersin.org/article/10.3389/fpsyg.2017.00557/fullspa
dc.source.bibliographicCitationRyan JJ, Lopez SJ. Wechsler Adult Intelligence Scale-III. En: Dorfman WI, Hersen M, editores. Understanding Psychological Assessment [Internet]. Boston, MA: Springer US; 2001 [citado 14 de octubre de 2019]. p. 19-42. Disponible en: http://link.springer.com/10.1007/978-1-4615-1185-4_2spa
dc.source.bibliographicCitationKreutzer JS, DeLuca J, Caplan B, editores. Encyclopedia of Clinical Neuropsychology [Internet]. New York, NY: Springer New York; 2011 [citado 14 de octubre de 2019]. Disponible en: http://link.springer.com/10.1007/978-0-387-79948-3spa
dc.source.bibliographicCitationBenedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test – Revised: Normative Data and Analysis of Inter-Form and Test-Retest Reliability. Clin Neuropsychol. febrero de 1998;12(1):43-55.spa
dc.source.bibliographicCitationJoska JA, Westgarth-Taylor J, Hoare J, Thomas KG, Paul R, Myer L, et al. Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study. BMC Infect Dis. diciembre de 2012;12(1):39.spa
dc.source.bibliographicCitationBottiggi KA, Chang JJ, Schmitt FA, Avison MJ, Mootoor Y, Nath A, et al. The HIV Dementia Scale: Predictive power in mild dementia and HAART. J Neurol Sci. septiembre de 2007;260(1-2):11-5.spa
dc.source.bibliographicCitationSkinner S, Adewale A, DeBlock L, Gill M, Power C. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy. HIV Med. abril de 2009;10(4):246-52.spa
dc.source.bibliographicCitationSacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. Aids. 2005;19(13):1367–1374.spa
dc.source.bibliographicCitationTsegaw M, Andargie G, Alem G, Tareke M. Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in South Wollo, Ethiopia. J Psychiatr Res. 1 de febrero de 2017;85:37-41.spa
dc.source.bibliographicCitationZhao T, Wei B, Long J, Tang X, Zhou M, Dang C. Cognitive disorders in HIV-infected and AIDS patients in Guangxi, China. J Neurovirol. 1 de febrero de 2015;21(1):32-42.spa
dc.source.bibliographicCitationJoska JA, Witten J, Thomas KG, Robertson C, Casson-Crook M, Roosa H, et al. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa. AIDS Behav. agosto de 2016;20(8):1621-31.spa
dc.source.bibliographicCitationMorgan EE, Woods SP, Scott JC, Childers M, Marquie Beck J, Ellis RJ, et al. Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale. J Clin Exp Neuropsychol. 4 de enero de 2008;30(1):83-90.spa
dc.source.bibliographicCitationFeatured Batteries - Cogstate Ltd [Internet]. Cogstate. [citado 14 de octubre de 2019]. Disponible en: https://www.cogstate.com/clinical-trials/computerized-cognitive-assessment/featured-batteries/spa
dc.source.bibliographicCitationCysique L, Maruff P, Darby D, Brew B. The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol. febrero de 2006;21(2):185-94.spa
dc.source.bibliographicCitationOverton ET, Kauwe JSK, Paul R, Tashima K, Tate DF, Patel P, et al. Performances on the CogState and Standard Neuropsychological Batteries Among HIV Patients Without Dementia. AIDS Behav. noviembre de 2011;15(8):1902-9.spa
dc.source.bibliographicCitationMoore DJ, Roediger MJP, Eberly LE, Blackstone K, Hale B, Weintrob A, et al. Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort. PloS One. 2012;7(11):e47310.spa
dc.source.bibliographicCitationU.S. Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau. Guide for HIV/AIDS Clinical Care. abril de 2014;spa
dc.source.bibliographicCitationBloch M, Kamminga J, Jayewardene A, Bailey M, Carberry A, Vincent T, et al. A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review. Clin Infect Dis Off Publ Infect Dis Soc Am. 1 de septiembre de 2016;63(5):687-93.spa
dc.source.bibliographicCitationKoski L, Brouillette M-J, Lalonde R, Hello B, Wong E, Tsuchida A, et al. Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment(*). HIV Med. septiembre de 2011;12(8):472-80.spa
dc.source.bibliographicCitationRichardson-Vejlgaard R, Dawes S, Heaton RK, Bell MD. Validity of cognitive complaints in substance-abusing patients and non-clinical controls: the Patient’s Assessment of Own Functioning Inventory (PAOFI). Psychiatry Res. 30 de agosto de 2009;169(1):70-4.spa
dc.source.bibliographicCitationPatton DE, Woods SP, Franklin D, Cattie JE, Heaton RK, Collier AC, et al. Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV. AIDS Behav. noviembre de 2012;16(8):2286-96.spa
dc.source.bibliographicCitationDoyle KL, Woods SP, Morgan EE, Iudicello JE, Cameron MV, Gilbert PE, et al. Health-Related Decision-Making in HIV Disease. J Clin Psychol Med Settings. 2016;23(2):135-46.spa
dc.source.bibliographicCitationThames AD, Arentoft A, Rivera-Mindt M, Hinkin CH. Functional disability in medication management and driving among individuals with HIV: A 1-year follow-up study. J Clin Exp Neuropsychol. enero de 2013;35(1):49-58.spa
dc.source.bibliographicCitationCattie JE, Doyle K, Weber E, Grant I, Woods SP, HIV Neurobehavioral Research Program (HNRP) Group. Planning deficits in HIV-associated neurocognitive disorders: component processes, cognitive correlates, and implications for everyday functioning. J Clin Exp Neuropsychol. 2012;34(9):906-18.spa
dc.source.bibliographicCitationEne L, Franklin DR, Burlacu R, Luca AE, Blaglosov AG, Ellis RJ, et al. Neurocognitive functioning in a Romanian cohort of young adults with parenterally-acquired HIV-infection during childhood. J Neurovirol. octubre de 2014;20(5):496-504.spa
dc.source.bibliographicCitationArentoft A, Byrd D, Monzones J, Coulehan K, Fuentes A, Rosario A, et al. Socioeconomic Status and Neuropsychological Functioning: Associations in an Ethnically Diverse HIV+ Cohort. Clin Neuropsychol. 2015;29(2):232-54.spa
dc.source.bibliographicCitationHeaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 7 de diciembre de 2010;75(23):2087-96.spa
dc.source.bibliographicCitationBeltrán M del C, Freyre M-Á, Hernández-Guzmán L. El Inventario de Depresión de Beck: Su validez en población adolescente. Ter Psicológica. abril de 2012;30(1):5-13.spa
dc.source.bibliographicCitationAmerican Psychological Association (APA). Beck Depression Inventory (BDI) [Internet]. https://www.apa.org. [citado 15 de octubre de 2019]. Disponible en: https://www.apa.org/pi/about/publications/caregivers/practice-settings/assessment/tools/beck-depressionspa
dc.source.bibliographicCitationWittchen H-U, Nelson CB. The Composite International Diagnostic Interview: An Instrument for Measuring Mental Health Outcome? En: Thornicroft G, Tansella M, editores. Mental Health Outcome Measures [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 1996 [citado 15 de octubre de 2019]. p. 179-87. Disponible en: https://doi.org/10.1007/978-3-642-80202-7_13spa
dc.source.bibliographicCitationCross S, Önen N, Gase A, Overton ET, Ances BM. Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol. diciembre de 2013;8(5):1114-22spa
dc.source.bibliographicCitationLawler K, Mosepele M, Ratcliffe S, Seloilwe E, Steele K, Nthobatsang R, et al. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study. J Int AIDS Soc. 20 de abril de 2010;13:15.spa
dc.source.bibliographicCitationDawes S, Suarez P, Casey CY, Cherner M, Marcotte TD, Letendre S, et al. Variable patterns of neuropsychological performance in HIV-1 infection. J Clin Exp Neuropsychol. agosto de 2008;30(6):613-26.spa
dc.source.bibliographicCitationWright E, Brew B, Arayawichanont A, Robertson K, Samintharapanya K, Kongsaengdao S, et al. Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology. 1 de julio de 2008;71(1):50-6.spa
dc.source.bibliographicCitationPereda M, Ayuso-Mateos JL, Gómez Del Barrio A, Echevarria S, Farinas MC, García Palomo D, et al. Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS. Psychol Med. enero de 2000;30(1):205-17.spa
dc.source.bibliographicCitationHeaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, et al. Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med. febrero de 1994;56(1):8-17.spa
dc.source.bibliographicCitationGibbs A, Andrewes DG, Szmukler G, Mulhall B, Bowden SC. Early HIV-related neuropsychological impairment: relationship to stage of viral infection. J Clin Exp Neuropsychol. octubre de 1990;12(5):766-80.spa
dc.source.bibliographicCitationYusuf AJ, Hassan A, Mamman AI, Muktar HM, Suleiman AM, Baiyewu O. Prevalence of HIV-Associated Neurocognitive Disorder (HAND) among Patients Attending a Tertiary Health Facility in Northern Nigeria. J Int Assoc Provid AIDS Care. febrero de 2017;16(1):48-55.spa
dc.source.bibliographicCitationFujiwara E, Tomlinson SE, Purdon SE, Gill MJ, Power C. Decision making under explicit risk is impaired in individuals with human immunodeficiency virus (HIV). J Clin Exp Neuropsychol. 2015;37(7):733-50.spa
dc.source.bibliographicCitationCrum-Cianflone NF, Moore DJ, Letendre S, Roediger MP, Eberly L, Weintrob A, et al. Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons. Neurology. 2013;80(4):371–379.spa
dc.source.bibliographicCitationVance DE, Burrage JW. Sleep disturbances and psychomotor decline in HIV. Percept Mot Skills. junio de 2005;100(3 Pt 2):1004-10.spa
dc.source.bibliographicCitationHinkin CH, Castellon SA, Hardy DJ. Dual task performance in HIV-1 infection. J Clin Exp Neuropsychol. febrero de 2000;22(1):16-24.spa
dc.source.bibliographicCitationWoods SP, Carey CL, Moran LM, Dawson MS, Letendre SL, Grant I. Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV. Arch Clin Neuropsychol. 1 de febrero de 2007;22(2):187-95.spa
dc.source.bibliographicCitationChernoff RA, Martin DJ, Schrock DA, Huy MP. Neuropsychological functioning as a predictor of employment activity in a longitudinal study of HIV-infected adults contemplating workforce reentry. J Int Neuropsychol Soc JINS. enero de 2010;16(1):38-48.spa
dc.source.bibliographicCitationYechoor N, Towe SL, Robertson KR, Westreich D, Nakasujja N, Meade CS. Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting. J Neurovirol. 2016;22(6):808-15.spa
dc.source.bibliographicCitationGuías Clínicas EACS Versión 8.0. octubre de 2015;73.spa
dc.source.bibliographicCitationFish J. Lawton-Brody Instrumental Activities of Daily Living Scale. En: Kreutzer JS, DeLuca J, Caplan B, editores. Encyclopedia of Clinical Neuropsychology [Internet]. New York, NY: Springer; 2011 [citado 27 de octubre de 2019]. p. 1438-9. Disponible en: https://doi.org/10.1007/978-0-387-79948-3_1842spa
dc.source.bibliographicCitationRobertson K, Bayon C, Molina J-M, McNamara P, Resch C, Muñoz-Moreno JA, et al. Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada. AIDS Care. 2014;26(12):1555-61.spa
dc.source.bibliographicCitationFazeli PL, Marceaux JC, Vance DE, Slater L, Long CA. Predictors of cognition in adults with HIV: implications for nursing practice and research. J Neurosci Nurs J Am Assoc Neurosci Nurses. febrero de 2011;43(1):36-50.spa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subjectDesorden Neurocognitivo Asociado a VIHspa
dc.subjectVirus de Inmunodeficiencia Humanaspa
dc.subjectEvaluaciónspa
dc.subjectDiagnósticospa
dc.subjectParticipación ocupacionalspa
dc.subjectSalud Mentalspa
dc.subjectRevisión sistemática de la literaturaspa
dc.subject.ddcCiencias médicas, Medicinaspa
dc.subject.keywordHIV-Associated Neurocognitive Disorderspa
dc.subject.keywordHIVspa
dc.subject.keywordHuman Immunodeficiency Virusspa
dc.subject.keywordAssessmentspa
dc.subject.keywordDiagnosiseng
dc.subject.keywordOccupational participationspa
dc.subject.keywordMental healthspa
dc.subject.keywordSystematic Reviewspa
dc.subject.lembMedicinaspa
dc.subject.lembEpidemiologíaspa
dc.titleAnálisis de la pertinencia de escalas de evaluación cognitiva y de funcionamiento ocupacional para el tamizaje y diagnóstico de alteraciones neurocognitivas asociadas al VIH. revisión sistemática de la literaturaspa
dc.typemasterThesiseng
dc.type.documentTesisspa
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.type.spaTesis de maestríaspa
local.department.reportEscuela de Medicina y Ciencias de la Saludspa
Archivos
Bloque original
Mostrando1 - 1 de 1
Miniatura
Nombre:
AguiaRojas-Karen-2019.pdf
Tamaño:
1.16 MB
Formato:
Adobe Portable Document Format
Descripción:
Documento de tesis
Descargar
Colecciones
Maestría en Epidemiología